Last Posted: Sep 03, 2019
- More Treatment Options Emerging for Some Men with Metastatic Prostate Cancer
NCI, 2019 - Using Big Data Techniques to Improve Prostate Cancer Reporting in the Gauteng Province, South Africa.
Cassim N et al. Studies in health technology and informatics 2019 Aug 2641437-1438 - A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk.
Bishop Madison R et al. PloS one 2019 14(8) e0220929 - The applications of metabolomics in the molecular diagnostics of cancer.
Cheung Pro Kit et al. Expert review of molecular diagnostics 2019 Aug - The role of miRNAs as biomarkers in prostate cancer.
Cozar J M et al. Mutation research 781165-174 - Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses.
Petralia Giuseppe et al. La Radiologia medica 2019 Mar 124(3) 218-233 - Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis.
Osses Daniël F et al. International journal of molecular sciences 2019 Apr 20(7) - Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.
Weber Marianne F et al. Public health research & practice 2019 Jul 29(2) - Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation.
Varnai Reka et al. Genes 2019 Aug 10(8) - Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
Bakavicius Arnas et al. Clinical epigenetics 2019 Aug 11(1) 115
.png)
No hay comentarios:
Publicar un comentario